ArticleHypertension research : official journal of the Japanese Society of Hypertension2024

Who benefits from the blood pressure-lowering effects of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease? - Obese or non-obese?

Kazuki ShiinaPubMed ↗Publisher ↗

No numbers read from the abstract.